ORIC Pharmaceuticals, Inc.

ORICNASDAQHealthcare● Active

$7.49

$-0.01(-0.13%)

Market Cap$775346539

P/E Ratio—

52W High$14.93

52W Low$7.23

Avg Volume1.9M

Open$7.63

Beta1.06

Cash on Hand Financials Revenue

ORIC Pharmaceuticals, Inc. (ORIC) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

ORIC · cash on hand · updated Dec 31, 2025

Core cash position

as of Dec 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$281.5M▲ +10.0% vs prior year

FY · as of Dec 31, 2025 · Reported in USD

Cash & Cash Equiv. (CCE)

$45.7M

cashAndCashEquivalents

Short-Term Investments

$235.8M

shortTermInvestments

YoY Change vs Prior Year

+10.0%

vs prior fiscal year

Latest Quarter

$281.9M

Q1 2026

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$281.5MCash on Hand

Total Debt$11.6MTotal Debt

Net Cash / Net Debt+$269.9MNet Cash Position

Cash vs Debt Ratio

Cash 96%ORIC Pharmaceuticals, Inc. cash as % of market cap: 36.30%% · MCap $1BDebt 4%

ORIC Pharmaceuticals, Inc. has a net cash position of $269.9M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$281.5M − $11.6M = +$269.9M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

ORIC annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

ORIC cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2025LatestFY$281.5M+10.0%

Dec 31, 2024FY$256.0M+22.9%

Dec 31, 2023FY$208.2M+0.9%

Dec 31, 2022FY$206.3M-13.0%

Dec 31, 2021FY$237.0M-19.3%

ORIC cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

ORIC vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

ORIC Pharmaceuticals, Inc.YOU

ORIC

$281.5M$776M36.3%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

ORIC Pharmaceuticals, Inc. (ORIC) cash on hand as of December 31, 2025 is $281.5M, comprising $45.7M in cash and cash equivalents (CCE) plus $235.8M in short-term investments — reported as ORIC Pharmaceuticals, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as ORIC Pharmaceuticals, Inc. cash reserves or cash position.

ORIC Pharmaceuticals, Inc. annual cash on hand history shows increased +10.0% in 2025: increased +10.0% in 2025. ORIC Pharmaceuticals, Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

ORIC Pharmaceuticals, Inc. carries total debt of $11.6M against cash of $281.5M, resulting in a net cash position of +$269.9M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

ORIC cash on hand · 5 questions

As of December 31, 2025, ORIC Pharmaceuticals, Inc. (ORIC) has $281,488,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $45,669,000 in cash and cash equivalents (CCE) plus $235,819,000 in short-term investments. Latest quarter (March 31, 2026): $281,932,000. Data sourced from the annual 10-K filing via FMP.

ORIC cash on handORIC cash reservesORIC cash 2025how much cash does ORIC have

▸ Source: FMP /balance-sheet-statement · US GAAP · ORIC Pharmaceuticals, Inc. · ORIC Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025